The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy

Reproductive Toxicology

Volumn 27, Issue 1, 2009, Pages 85-87

  Svirsky, Ran ^a   Rozovski, Uri ^b   Vaknin, Zvi ^a   Pansky, Moty ^a   Schneider, David ^a   Halperin, Reuvit ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Birth defect; Ectopic pregnancy; Methotrexate; Outcome; Pregnancy

Indexed keywords

METHOTREXATE;

ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CONCEPTION; CONTROLLED STUDY; DEPENDENT VARIABLE; ECHOGRAPHY; ECTOPIC PREGNANCY; FEMALE; FOLLOW UP; HUMAN; INDEPENDENT VARIABLE; KARYOTYPE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; PREGNANCY; PREGNANCY OUTCOME; TERATOGENICITY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; CONGENITAL ABNORMALITIES; FEMALE; FERTILIZATION; HUMANS; ISRAEL; METHOTREXATE; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, ECTOPIC; SAFETY; TIME FACTORS;

EID: 59049099024     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.11.055     Document Type: Article

References (19)

1. Jukes T.H. The history of methotrexate. Cutis 21 (1978) 396-398
2. Conaghan P.G., and Brooks P. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine. Curr Opin Rheumatol 7 (1995) 167-173
3. Andreasen P.B., Hansen J.M., Skovsted L., and Siersbaek-Nielsen K. Folic acid and phenytoin metabolism. Lancet 1 (1971) 645
4. Smithells R.W., Sheppard S., Schorah C.J., Seller M.J., Nevin N.C., Harris R., et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1 (1980) 339-340
5. Jordan R.L., Wilson J.G., and Schumacher H.J. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 15 (1977) 73-79
6. Brewton R.G., and MacCabe J.A. Studies of methotrexate-induced limb dysplasias utilizing a 51chromium release assay. Teratology 41 (1990) 211-221
7. Skalko R.G., and Gold M.P. Teratogenicity of methotrexate in mice. Teratology 9 (1974) 159-163
8. Powell H.R., and Ekert H. Methotrexate-induced congenital malformations. Med J Aust 2 (1971) 1076-1077
9. Lloyd M.E., Carr M., McElhatton P., Hall G.M., and Hughes R.A. The effect of methotrexate on pregnancy, fertility and lactation. Q J Med 92 (1999) 551-563
10. Stovall T., and Ling F. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 168 (1993) 1759-1765
11. Stovall T.G., Ling F.W., and Gray L.A. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77 (1991) 754-757
12. Gervaise A., Masson L., de Tayrac R., Frydman R., and Fernandez H. Reproductive outcome after methotrexate treatment of tubal pregnancies. Fertil Steril 82 (2004) 304-308
13. Stika C.S., Anderson L., and Frederiksen M.C. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol 174 (1996) 1840-1846 [discussion 6-8]
14. Yedlinsky N.T., Morgan F.C., and Whitecar P.W. Anomalies associated with failed methotrexate and misoprostol termination. Obstet Gynecol 105 (2005) 1203-1205
15. AHFS Drug information; 1996. p. 751-9.
16. Charache S., Condit P.T., and Humphreys S.R. Studies on the folic acid vitamins. IV. The persistence of amethopterin in mammalian tissues. Cancer 13 (1960) 236-240
17. Donnenfield A.E. Methotrexate exposure prior and during pregnancy. Teratology 49 (1994) 79-81
18. Rustin G.J., Booth M., Dent J., Salt S., Rustin F., and Bagshawe K.D. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J (Clin Res Ed) 288 (1984) 103-106
19. ABPI Compendium of Data Sheets and Summaries of Product characteristics 1996-97. Datapharm Publications.